Filing Details

Accession Number:
0001209191-23-056944
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-29 20:49:40
Reporting Period:
2023-11-27
Accepted Time:
2023-11-29 20:49:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1496323 Igm Biosciences Inc. IGMS Pharmaceutical Preparations (2834) 770349194
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1787359 Misbah Tahir C/O Igm Biosciences, Inc.
325 E Middlefield Road
Mountain View CA 94043
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-15 234 $11.71 50,945 No 5 A Direct
Common Stock Disposition 2023-11-27 1,337 $5.06 49,608 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 S Direct
Footnotes
  1. The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  3. This transaction was executed in multiple trades at prices ranging from $4.96 to $5.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.